Order Today Lorbriqua (Lorlatinib) 100 mg Tablets Online at Best Price United Kingdom - London, Sheffield, Manchester, Bristol, Cambridge, Oxford, Cardiff, Leicester, USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.

Lorbriqua (Lorlatinib) 100 mg Tablets 

Introduction

Lorbriqua (Lorlatinib) 100 mg Tablets is a targeted anti-cancer medication used primarily in the treatment of advanced lung cancer. It belongs to a class of drugs known as ALK (Anaplastic Lymphoma Kinase) inhibitors, which are designed to block specific proteins responsible for cancer growth.

This medicine is widely prescribed for patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), especially those who have developed resistance to earlier treatments.

Composition and Content

• Active Ingredient: Lorlatinib 100 mg
• Drug Class: Tyrosine Kinase Inhibitor (TKI)
• Form: Oral Tablets

Lorlatinib works by targeting abnormal ALK and ROS1 proteins that promote tumor growth, effectively slowing or stopping cancer progression.

How to Use

• Take the tablet orally with or without food.
• Swallow whole with water; do not crush or chew.
• Take at the same time every day for best results.
• Follow your oncologist’s instructions strictly.

Dosage

• Standard Dose: 100 mg once daily
• Dose adjustments may be required based on:
  • Side effects
  • Liver function
  • Drug interactions

⚠️ Always consult a healthcare professional before changing dosage.

Contact Details

🌐 Website: https://globmedindia.com
📧 Email: info@globmedindia.com
📞 Phone: +91 9730316395

💬 WhatsApp: +91 9730316395

Uses

Lorbriqua (Lorlatinib) is used for:

• Treatment of ALK-positive non-small cell lung cancer (NSCLC)
• Patients who:
  • Have progressed after prior ALK inhibitor therapy
  • Show resistance to earlier treatments

Treatment Benefits

• Targets cancer at a molecular level
• Effective in brain metastases (crosses blood-brain barrier)
• Suitable for patients with treatment-resistant lung cancer
• Improves progression-free survival

Advantages

• Highly specific targeted therapy
• Oral administration (no hospitalization needed)
• Effective against advanced-stage cancers
• Better management of tumor spread to brain

Possible Side Effects

• Increased cholesterol or triglycerides
• Swelling (edema)
• Mood changes or cognitive effects
• Fatigue
• Weight gain

⚠️ Regular monitoring and blood tests are recommended.

Storage Conditions

• Store at room temperature (20°C to 25°C)
• Keep away from moisture and direct sunlight
• Keep out of reach of children

Alternative Indian Brands of Lorlatinib

Some alternative brands available in India include:

• Lorlatinib Tablets by Natco Pharma
• Lorlatinib by Dr. Reddy’s Laboratories
• Lorlatinib by Hetero Healthcare
• Lorlatinib by Zydus Cadila

These brands offer cost-effective options with similar efficacy.

Buy Lorbriqua (Lorlatinib) 100 mg Tablets Online at Best Price

Looking to buy Lorbriqua Lorlatinib 100 mg Tablets online? GlobMedIndia is a trusted medicine exporter from India, offering genuine and high-quality anti-cancer medicines at competitive prices.

We specialize in global supply of oncology medicines, ensuring safe and timely delivery to countries including:

• Saudi Arabia: Riyadh, Jeddah, Mecca, Medina, Dammam
• United States & United Kingdom: Cambridge, London
• UAE & Middle East: Dubai, Abu Dhabi
• Europe, Australia, Africa & Southeast Asia
• Countries: Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, South Korea, Thailand, Vietnam

Why Choose GlobMedIndia?

• ✔ 100% Genuine Medicines
• ✔ WHO-GMP Certified Suppliers
• ✔ Competitive Export Prices
• ✔ Fast & Safe International Delivery
• ✔ Expert Support for Bulk Orders

Order Lorbriqua (Lorlatinib) Tablets Today

GlobMedIndia ensures hassle-free ordering and doorstep delivery worldwide, making life-saving cancer treatments accessible globally.

Conclusion

Lorbriqua (Lorlatinib) 100 mg Tablets is a breakthrough therapy for patients suffering from ALK-positive lung cancer, especially in advanced stages. With its targeted mechanism and effectiveness against resistant cancer cells, it significantly improves patient outcomes.

GlobMedIndia stands as a reliable partner in delivering high-quality anti-cancer medicines globally, ensuring accessibility, affordability, and trust.